相关实验视频
Updated: Jun 7, 2025

10:03
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
25.7K
在以前没有服用过药物的2型糖尿病患者中,现实世界中的治疗模式:初始组合疗法与连续的步骤疗法对比
Journal of the American Pharmacists Association : JAPhA
|November 13, 2024
概括
许多2型糖尿病 (T2D) 患者缺乏最佳的血糖控制. 这项研究检查了现实世界的治疗启动,发现10-12%的新患者接受了初始组合疗法,而不是标准的步骤疗法.
科学领域:
- 内分泌学 在内分泌学.
- 药物治疗 药物治疗
- 现实世界的证据.
背景情况:
- 低于最佳的血糖控制影响了许多2型糖尿病 (T2D) 患者,尽管有指导方针.
- 目前的T2D护理往往涉及单一治疗,其次是附加治疗.
- 早期的密集血糖控制可以改善长期结果并减少并发症.
研究的目的:
- 为了研究新诊断的,未使用过药物的T2D患者的治疗启动模式.
- 在现实环境中比较初始组合疗法与步骤疗法.
- 确定与不同治疗启动方法相关的因素.
主要方法:
- 对索赔数据 (2017-2019年) 的回顾性分析.
- 包括从未使用过药物的T2D患者与持续招募.
- 分类为初始组合疗法或步骤疗法队列.
主要成果:
- 分析了超过136,000名患者 (商业/医疗保险和医疗补助).
- 10-12%的患者开始接受组合治疗.
- 人口和临床因素影响了组合治疗和分步治疗之间的选择.
结论:
- 关于T2D治疗启动的现实数据有限.
- 结果提供了对T2D药物治疗当前临床实践的见解.
- 研究可以为糖尿病管理的临床决策提供信息.
相关概念视频
Diabetes: Management and Pharmacotherapy
236
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
236
Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39
Insulin: Dosing Regimen and Adverse Effects
146
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
146
Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Oral Hypoglycemic Agents: Biguanides and Glitazones
174
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
174
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K

